These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19900028)

  • 1. Patent foramen ovale and cryptogenic stroke: a complex neuro-cardio-vascular problem.
    Spies C; Wong M
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1455-67. PubMed ID: 19900028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptogenic stroke and patent foramen ovale.
    Thaler DE; Saver JL
    Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale and cryptogenic stroke.
    Jaquis J
    Dimens Crit Care Nurs; 2007; 26(6):233-6. PubMed ID: 18090138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical embolism via a patent foramen ovale: an important mechanism of cryptogenic strokes.
    Rahman A; Jayasinghe R; Rajendran S
    Circ Cardiovasc Imaging; 2008 Sep; 1(2):e9-e10. PubMed ID: 19808523
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent foramen ovale and cryptogenic stroke in older patients.
    Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
    N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes.
    Staubach S; Bertog S; Wunderlich N; Sievert H
    Future Cardiol; 2009 Sep; 5(5):503-10. PubMed ID: 19715414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic significant patent foramen ovale: giving patent foramen ovale management back to the cardiologist.
    Rigatelli G; Cardaioli P; Chinaglia M
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):573-7. PubMed ID: 18307240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFO and paradoxical embolism producing events other than stroke.
    Dao CN; Tobis JM
    Catheter Cardiovasc Interv; 2011 May; 77(6):903-9. PubMed ID: 21207422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
    Eggers AE
    Med Hypotheses; 2006; 67(5):1072-5. PubMed ID: 16814938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFO and stroke: what are the data?
    Wechsler LR
    Cardiol Rev; 2008; 16(1):53-7. PubMed ID: 18091402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent foramen ovale and cryptogenic stroke.
    Nakanishi K; Yoshiyama M; Homma S
    Trends Cardiovasc Med; 2017 Nov; 27(8):575-581. PubMed ID: 28709812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should patent foramen ovale be closed in patients with recent cryptogenic stroke or presumptive platypnea-orthodeoxia syndrome?
    Saeed G
    Tex Heart Inst J; 2011; 38(2):214-5. PubMed ID: 21494544
    [No Abstract]   [Full Text] [Related]  

  • 16. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.
    Weimar C; Holle DN; Benemann J; Schmid E; Schminke U; Haberl RL; Diener HC; Goertler M;
    Cerebrovasc Dis; 2009; 28(4):349-56. PubMed ID: 19628936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
    Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects of paradoxical embolism.
    Lehmeyer S; Lindhoff-Last E
    Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.